| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adrenocortical carcinoma: The management of metastatic disease
|
Fay, André P.
|
|
2014
|
92 |
2 |
p. 123-132
10 p.
|
artikel
|
| 2 |
Editorial Board
|
|
|
2014
|
92 |
2 |
p. IFC-
1 p.
|
artikel
|
| 3 |
Linking the activity of bortezomib in multiple myeloma and autoimmune diseases
|
Škrott, Zdeněk
|
|
2014
|
92 |
2 |
p. 61-70
10 p.
|
artikel
|
| 4 |
Nras in melanoma: Targeting the undruggable target
|
Mandalà, Mario
|
|
2014
|
92 |
2 |
p. 107-122
16 p.
|
artikel
|
| 5 |
Primary systemic therapy and whole breast irradiation for locally advanced breast cancer: A systematic review
|
Kaidar-Person, Orit
|
|
2014
|
92 |
2 |
p. 143-152
10 p.
|
artikel
|
| 6 |
Radiation-enhanced cell migration/invasion process: A review
|
Moncharmont, Coralie
|
|
2014
|
92 |
2 |
p. 133-142
10 p.
|
artikel
|
| 7 |
Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: An up-to-date meta-analysis
|
Qi, Wei-Xiang
|
|
2014
|
92 |
2 |
p. 71-82
12 p.
|
artikel
|
| 8 |
What could Nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?
|
Capdevila, Jaume
|
|
2014
|
92 |
2 |
p. 83-106
24 p.
|
artikel
|
Tijdschrift beschrijving